A new therapy for advanced pancreatic cancer, one of the most difficult-to-treat diseases, has been approved by the US Food and Drug Administration. The combination therapy has been approved for patients who have previously received gemcitabine. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
